School of Health Sciences
Biology: Biomedical Sciences
Human rotavirus, HRV, rotavirus, Immunoglobulin Y, IgY, anti-HRV IgY, passive oral immunotherapy, adjunct therapy, rotavirus vaccines, child mortality, Millennium Development Goals, Sustainable Development Goals
Digestive System Diseases | Gastroenterology | Infectious Disease | Medical Immunology | Medicine and Health Sciences | Pediatrics | Preventive Medicine | Public Health | Virus Diseases
Brown, Christa, "Treatment and Prevention of Human Rotavirus (HRV) in Developing Countries: The Potential of Avian Immunoglobulin Y" (2016). Senior Honors Theses. 616.
Rotavirus gastroenteritis is a leading cause of childhood mortality, killing ~1400 children younger than five daily, primarily through severe diarrheal dehydration. Eighty-five percent of this mortality occurs in developing countries where rotavirus vaccines are not widely implemented and are only partially effective. In those countries, it has proven difficult to implement the recommended supportive therapies like oral rehydration therapy (ORT) on a wide scale due to lack of both medical infrastructure and private economic investment combined with cultural bias against ORT. IgY targeting human rotavirus (anti-HRV IgY) shows potential as a passive immunotherapy that reduces rotavirus-associated morbidity and mortality, augments vaccine and ORT implementation measures, and, with international and local investment, overcomes the current barriers to rotavirus treatment and prevention.
Fig. 1. copyright permission
NatureReviewsLicense-Rotavirus Particle.pdf (141 kB)
Fig. 2. copyright permission
Figure Permission Kovacs Nolan.JPG (58 kB)
Fig. 3. & Fig. 4. copyright permission
RightsLink Printable License--Seq Separation.pdf (134 kB)
Fig. 5. copyright permission
Digestive System Diseases Commons, Gastroenterology Commons, Infectious Disease Commons, Medical Immunology Commons, Pediatrics Commons, Preventive Medicine Commons, Public Health Commons, Virus Diseases Commons